Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection

New Microbiologica

Volumn 21, Issue 4, 1998, Pages 375-378

  Giordano, A ^a   Magni, A ^a   Filadoro, F ^a   Graziani, C ^a   Quattrucci, S ^a   Cipriani, P ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Cistic Fibrosis; Immunoglobulins; Pseudomonas aeruginosa

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ARTICLE; BLOOD; CYSTIC FIBROSIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; INFANT; LONGITUDINAL STUDY; MICROBIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOGLOBULIN G; INFANT; LONGITUDINAL STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0032175079     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. CIOFU, O., GIWERCMAN, B., PEDERSEN, S.S., and HØIBY, N. (1994). Development of antibiotic resistence in Pseudomonas aeruginosa during two decedes of antipseudomonal treatment at the Danish CF Center. Acta Pathologica Microbiologica et Immunologien Scandinava, 102, 674-680.
2. CORDON, S.M., HELBORN, J.S., RAYNER, R.J., HILLER, E.J., and SHALE, D.J. (1992). IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. Archives of Disease inChildhood, 67, 737-740.
3. COWAN, R.G, and WINNIE, G.B. (1993). Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function neutrophil chemotaxis and phagocytosis. Journal of Clinical Immunology, 13, 359-370.
4. FITZ SIMMONS, S.C. (1993). The changing epidemiology of cystic fibrosis. Journal of Pediatrics, 122, 1-9.
5. HØIBY, N., and AXELSEN, N.H. (1973). Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel. Acta Pathologica Microbiologica et Immunologica Scandinava, B 81, 298-308.
6. LIKAVCANOVA, E., and LAGACE, J. (1992). Quantitative analysis of immunoglobulin G subclass responses to Pseudomonas aeruginosa antigens in cystic fibrosis. Journal of Medical Microbiology, 36, 437-444.
7. LUGTENBERG, B., HEIJERS, J., PETERS, R., VAN DER HOCK, P., and VAN ALPHEN, L. (1975). Electrophoretic resolution of the maior outer membrane protein of E. coli K12 into four bands. FEBS Letters, 58(1), 254-258.
8. PEDERSEN, S.S., KOCH, C., and HØIBY, N. (1992). Prevention and early treatment of Pseudomonas aeruginosa infection In: Høiby N. and Pedersen S.S. (Eds.): Cystic fibrosis basic and clinical research. Elsevier Amsterdam, pp. 135-144.
9. PEDERSEN, S.S., HØIBY, N., ESPERSEN, F., and KOCH, C. (1992). Role of algynate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax, 47, 6-13.
10. PRESSLER, T., JENSEN, E.T., ESPERSEN, F., PEDERSEN, S.S., and HØIBY, N. (1995). High levels of complement-activation capacity in sera from patients with cystic fibrosis correlate with high levels of IgG3 antibodies to Pseudomonas aeruginosa antigens and poor lung function. Pediatric Pulmonology, 20, 71-77.
11. PRESSLER, T., JENSEN, E.T., ESPERSEN, F., PEDERSEN, S.S., HØIBY, N., and KOCH, C. (1994). Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pediatric Pulmonology, 17, 31-40.
12. SHWAUCHMAN, H., and KULCZYCKI, L.L. (1958). Long-term study of one hundred and five patients with cystic fibrosis. American Journal of Disease in Childwood, 96, 6-15.
13. TOWBIN, H., STAEHLIN, T., and GORDON, J. (1979). Electrophoretic transer proteins from polyacrylamide gels nitrocellulose sheets: procedure and some applications. Proceedings of the National Academic of Sciences, 76, 4350-54.
14. TRANCASSINI, M., DE VITO, D., CIMMINO, G., ANTONELLI, M., QUATTRUCCI, S., and CIPRIANI, P. (1996). Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients. European Journal of Clinical Microbiology and Infectious Diseases, 15, 309-312.
15. VASQUEZ, C., MUNICIO, M., CORERA, M., GAZTELURRUTIA, I., SOJO, A., and VITORIA, J.C. (1993). Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Acta Paediatrica, 82, 308-309.